Abstracts tagged "Health Services Research"

Abstract Number: 0148 • ACR Convergence 2021
Implementation of an Interprofessional Safety Check to Screen for Latent Tuberculosis at an Academic Tertiary Referral Rheumatology Clinic Increased Screening Rates Compared to Historical Levels
Meera Subash, Hailyn Nielsen, Neda Noori Nassr, Diana Ung and Andrew Gross, University of California San Francisco, San Francisco, CA
Background/Purpose: Certain disease-modifying anti-rheumatic drugs (DMARDs) increase the risk of reactivation of latent tuberculosis (TB). While screening for latent TB prior to initiation of these…
Abstract Number: 1075 • ACR Convergence 2021
The Impact of an Integrated Care Management Program on Acute Care Use for Potentially Avoidable Conditions Among High-Risk Patients with SLE
Jessica Williams¹, Kreager Taber¹, Weixing Huang¹, Jamie Collins¹, Rebecca Cunningham¹, Katherine Concannon¹, Christine Vogeli², Lisa Wichmann¹ and Candace Feldman¹, ¹Brigham and Women's Hospital, Boston, MA, ²Massachusetts General Hospital, Boston, MA
Background/Purpose: Patients with SLE are disproportionately from populations with lower socioeconomic status and poorer access to health care, placing them at risk for potentially avoidable…
Abstract Number: 0154 • ACR Convergence 2021
Utilization of Magnetic Resonance Imaging in Early Rheumatoid Arthritis: Results from a Population-based Cohort (1999-2014)
Caitrin Coffey¹, Cynthia Crowson², Cassondra Hulshizer¹, Gavin McKenzie¹, Nicholas Rhodes¹, John Davis¹ and Kerry Wright¹, ¹Mayo Clinic, Rochester, MN, ²Mayo Clinic, Eyota, MN
Background/Purpose: Early diagnosis and treatment initiation improve outcomes for patients with rheumatoid arthritis (RA). Delays to diagnosis and treatment affect patients with seronegative vs seropositive…
Abstract Number: 1079 • ACR Convergence 2021
A Multifaceted Approach to Increasing Enrollment and Activation of Pediatric Rheumatology Patient Portal Profiles
Y. Ingrid Goh¹, Ma'Anne Gawaran¹, Neelam Walji-Jivraj¹, Kristi Whitney², Christine O'Brien¹, Tala El Tal³, Shirley Tse², Deborah Levy¹, Brian Feldman¹, Holly Convery¹, Audrey Bell-Peter¹, Michelle Anderson¹, Lynn Spiegel¹, Dilan Dissanayake¹, Chelsea DeCoste¹, Raphael Kraus¹, Jayne MacMahon¹, Jeanine McColl¹, Alaa Shehab¹, Paul Tsoukas⁴, Linda Hiraki¹, Andrea Knight⁴, Elizaveta Limenis¹, Rayfel Schneider¹, Ruud Verstegen¹, Rae Yeung¹, Alexa Latourelle¹, Leah Moscato¹, Alisha Panjwani¹ and Ronald Laxer², ¹The Hospital for Sick Children, Toronto, ON, Canada, ²SickKids, Toronto, ON, Canada, ³University of Toronto/Hospital for Sick Children, Toronto, ON, Canada, ⁴Hospital for Sick Children, Toronto, ON, Canada
Background/Purpose: Patient portals provide patients and caregivers the opportunity to be more engaged in their healthcare, as it promotes autonomy and encourages patients and caregivers…
Abstract Number: 0424 • ACR Convergence 2021
Incremental Healthcare Costs of Eosinophilic Granulomatosis with Polyangiitis (EGPA) Compared to Asthma: Retrospective Analysis of Commercial Claims Data in the United States (US)
Christopher Bell¹, Juliana Meyers² and Mayank Ajmera², ¹GlaxoSmithKline, Research Triangle Park, NC, ²RTI-Health Solutions, Research Triangle Park, NC
Background/Purpose: Eosinophilic granulomatosis with polyangiitis (EGPA), formerly Churg-Strauss Syndrome, is a rare, complex multisystem disorder, characterized by vascular inflammation and multisystem organ damage. EGPA manifests…
Abstract Number: 1080 • ACR Convergence 2021
Effect of Triage by a Rheumatologist in a Primary Care Setting
Elke van Delft¹, Deirisa Lopes Barreto², Huub Han¹, Ilja Tchetverikov³, Adrie Evertse⁴, Martijn Kuijper¹, Mieke Hazes⁵ and Angelique Weel-Koenders¹, ¹Maasstad Hospital Rotterdam, Rotterdam, Netherlands, ²Maasstad Hospital Rotterdam, Rotterdam, ³Albert Schweitzer Hospital, Dordrecht, Netherlands, ⁴Medical Centre Molenaar, Oud-Beijerland, Netherlands, ⁵Erasmus Medical Center Rotterdam, Rotterdam, Netherlands
Background/Purpose: General practitioners have difficulties recognising inflammatory rheumatic diseases (IRD), reflected by a low incidence rate of IRD in newly referred arthralgia patients. On the…
Abstract Number: 0464 • ACR Convergence 2021
The Impact of Timely Post-Discharge Follow-up on Readmission Risk Among Patients with Systemic Lupus Erythematosus
Maria Schletzbaum¹, Nadia Sweet², W Ryan Powell², Andrea Gilmore Bykovskyi³, Farah Kaiksow², Ann Sheehy², Amy Kind² and Christie Bartels², ¹University of Wisconsin School of Medicine and Public Health, Middleton, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI, ³University of Wisconsin - Madison School of Nursing, Madison, WI
Background/Purpose: Systemic lupus erythematosus (SLE) has the 6th highest hospital readmission rate of all US chronic diseases with significant health disparities and costs. Transitional care…
Abstract Number: 1081 • ACR Convergence 2021
Improving Rheumatology Resource Utilization and Access to Specialty Care for Patients with Early Inflammatory Arthritis Through Enhanced Triage
Kristina Roche¹, John Hanly¹, Jennifer MacKinnon², Susan Parlee², Trudy Taylor¹, Volodko Bakowsky¹, Cheri Gunn², Nikolas Harris³ and Janet Roberts⁴, ¹Dalhousie University, Halifax, NS, Canada, ²Nova Scotia Health Authority, Halifax, NS, Canada, ³The Arthritis Society, Halifax, NS, Canada, ⁴Dalhousie University, Halifac, NS, Canada
Background/Purpose: In many health care jurisdictions the demand for rheumatology consultation exceeds the capacity to provide timely access for all referrals. This has highlighted the…
Abstract Number: 0600 • ACR Convergence 2021
A Cohort Study of Retention in Ambulatory Lupus Care Among Medicare Patients with SLE-related Hospitalizations
Maria Schletzbaum¹, Carlos Torres², Amy Kind², Andrea Gilmore Bykovskyi³, Ann Sheehy² and Christie Bartels², ¹University of Wisconsin School of Medicine and Public Health, Middleton, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI, ³University of Wisconsin - Madison School of Nursing, Madison, WI
Background/Purpose: In other conditions that require chronic management, poor retention in ambulatory care is associated with adverse outcomes. We previously identified that living in the…
Abstract Number: 1138 • ACR Convergence 2021
Assessing Trends in Dual Energy X-Ray Absorptiometry (DXA) Utilization Among Medical Providers in the United States
Timothy Edgil¹, Kenneth Saag², Jeffrey Curtis³ and Maria I. Danila², ¹Division of General Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, ²University of Alabama at Birmingham, Birmingham, AL, ³Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: The twenty first century has seen falling reimbursement rates for dual energy X-ray absorptiometry (DXA) testing coupled with a rising elderly population in the…
Abstract Number: 0641 • ACR Convergence 2021
Title: EHR-Supported Staff Protocol Improves Smoking Cessation in a Diverse Rheumatology Clinic: Updated Results of Quit Connect Dissemination
Jennifer Brandt¹, Edmond Ramly², Monica Messina³, S Sam Lim⁴ and Christie Bartels³, ¹Emory School of Medicine, Atlanta, GA, ²University of Wisconsin School of Medicine, Madison, WI, ³University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁴Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA
Background/Purpose: Smoking is a risk factor for rheumatologic conditions like lupus and rheumatoid arthritis and predicts worse outcomes. Smoking and rheumatic disease increase risk for…
Abstract Number: 1154 • ACR Convergence 2021
What Do Patients Know About Biosimilars and How Satisfied Are They with the Educational Process? – A Systematic Comparison Between Rheumatologists and Nurse Specialists, Including Effects of Multiswitching
Sabina Gall, Uta Kiltz, Tanja Kobylinski, Ioana Andreica, Kristina Vaupel, Xenofon Baraliakos and Jürgen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany
Background/Purpose: The market share of biosimilars (bsDMARDs) is steadily growing, not only in rheumatologic care. Although data on efficacy, efficiency and safety have been generated…
Abstract Number: 0643 • ACR Convergence 2021
Tailored BP Connect Protocol with Implementation Support for Rheumatology Clinic Staff Exceeds Non-tailored Protocol at Improving Primary Care Referrals for Blood Pressure Follow-up
David Gazeley¹, Monica Messina², Edmond Ramly², Ann Rosenthal¹, Laurie Lapp², Laura Stewart³ and Christie Bartels², ¹Medical College of Wisconsin, Milwaukee, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI, ³Froedtert & Medical College of Wisconsin, Milwaukee, WI
Background/Purpose: Many rheumatic diseases increase risk of cardiovascular disease, yet an important modifiable cardiovascular risk factor, high blood pressure (BP), often remains unaddressed during rheumatology…
Abstract Number: 1272 • ACR Convergence 2021
Characterizing Patient and Physician Perceptions of Systemic Lupus Erythematosus (SLE) Disease Burden Using Traditional Rheumatoid Arthritis Outcomes Measures
Christopher Bell¹, Shirley Huang¹, Meg Wang², Maral DerSarkissian², Mei Sheng Duh², Bhavna Dhillon³, Carlyne Averell¹, Bernie Rubin¹ and Daniel Wallace⁴, ¹GlaxoSmithKline, Research Triangle Park, NC, ²Analysis Group, Boston, MA, ³United Rheumatology, Hauppauge, NY, ⁴Cedars-Sinai, Los Angeles, CA
Background/Purpose: SLE is a chronic, autoimmune disease affecting multiple organ systems, and characterized by fluctuating disease activity. Many SLE disease measures may be impractical for…
Abstract Number: 0644 • ACR Convergence 2021
Follow-up Scheduling Appears Essential for Success of Rheumatology High Blood Pressure Protocol Across Health Systems
Christie Bartels, Bret Hanlon, Monica Messina, Sancia Ferguson and Edmond Ramly, University of Wisconsin School of Medicine and Public Health, Madison, WI
Background/Purpose: To address high blood pressure (BP), target of two ACR quality measures and the leading modifiable risk factor for cardiovascular disease, we previously developed…

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].